Today: 20 May 2026
Chevron stock slips as oil tumbles on U.S.-Iran talk; HSBC downgrades CVX
2 February 2026
1 min read

Chevron stock slips as oil tumbles on U.S.-Iran talk; HSBC downgrades CVX

New York, Feb 2, 2026, 11:04 EST — Regular session

  • Chevron shares fell about 1.4% in morning trading, tracking a sharp drop in crude prices.
  • HSBC cut Chevron to “hold” from “buy,” lifting its price target to $180.
  • Traders are watching oil headlines and Chevron’s Feb. 17 dividend record date.

Chevron stock (CVX) fell 1.4% to $174.50 by 10:48 a.m. EST on Monday, pressured by a slide in oil prices and a broker downgrade.

The move matters because Chevron’s earnings power still hinges on crude. When oil drops fast, investors tend to reprice cash flow, buybacks and the “how safe is the dividend?” question, even for the biggest integrated producers.

It also lands after a strong January run for energy shares. That rally left less room for error, especially with fresh Middle East headlines pushing oil the other way.

Brent crude and U.S. West Texas Intermediate (WTI) — the two main global oil benchmarks — fell about 5% after Donald Trump said Iran was “seriously talking” with Washington, easing fears of supply disruption. PVM Oil Associates analyst Tamas Varga called it the “disappearance of the geopolitical risk premium,” while OPEC+ kept March output unchanged. Reuters

Other oil majors slid with it. Exxon Mobil fell about 1.6% and ConocoPhillips lost about 1.9%.

In a note, Kim Fustier at HSBC downgraded Chevron to “hold” from “buy” and raised the price target to $180 from $169, saying a roughly 16% year-to-date rise had left valuations “stretched.” Investing.com

Chevron said on Jan. 30 that fourth-quarter earnings were $2.8 billion, or $1.39 per share, and adjusted earnings were $1.52 per share. In the same release, it raised the quarterly dividend 4% to $1.78 a share, payable March 10 to holders of record on Feb. 17 — the date shareholders must be on the books to get the payout.

The risk for Chevron bulls is that oil can keep falling after a big run-up, and the stock usually won’t fight that tape for long. On the flip side, any reversal in Middle East diplomacy or a new supply shock can put a floor back under crude, quickly.

For now, traders are watching crude for fresh Washington-Tehran headlines and what they do to the “risk premium,” with Chevron’s Feb. 17 record date for the higher dividend next on the company calendar.

Stock Market Today

  • Okta (OKTA) Stock Declines Amid Market Despite Strong Earnings Outlook
    May 19, 2026, 7:32 PM EDT. Okta (OKTA) shares fell 1.68% to $74.45, underperforming the S&P 500's slight 0.02% decline. The cloud identity management firm is expected to report earnings per share (EPS) of $0.57, a 29.55% increase year-over-year, and revenue of $649.35 million, up 11.19%. Annual forecasts predict EPS of $2.61 and revenue of $2.56 billion, marking increases of 63.13% and 13.19%, respectively. Despite the recent stock drop, Okta holds a Zacks Rank #1 (Strong Buy), reflecting optimistic analyst revisions. The stock trades at a forward price-to-earnings ratio of 29.07, above the industry average of 17.59, and a PEG ratio of 1.26 compared to the industry's 1.58, indicating valuation relative to earnings growth.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Dow Jones today: DJIA turns higher after metals shock as jobs report and Big Tech earnings loom
Previous Story

Dow Jones today: DJIA turns higher after metals shock as jobs report and Big Tech earnings loom

Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next
Next Story

Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next

Go toTop